Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

Journal of Hypertension
Carmine Zoccali

Abstract

The endogenous inhibitor of the nitric oxide synthase, asymmetric dimethylarginine (ADMA), by reducing nitric oxide (NO) availability, may trigger pro-atherogenic effects. A high plasma concentration of this substance has been associated to intima-media thickening, left ventricular hypertrophy and all-cause and cardiovascular mortality in patients with end-stage renal disease, and to coronary events in males in the general population. Recent studies show that ADMA predicts renal disease progression and death in patients with moderate to severe renal insufficiency. ADMA may be at the crossroad of the atherosclerosis process and may represent an important factor in the high risk associated with renal insufficiency.

References

Oct 1, 1988·Hypertension·S MoncadaE A Higgs
Sep 1, 1995·The American Journal of Physiology·R G BogleP Vallance
Nov 1, 1994·Journal of the American Society of Nephrology : JASN·D BatlleL Gomez
Mar 1, 1996·Hypertension·D L Mattson, D J Higgins
Dec 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R J MacAllisterE Ritz
Mar 1, 1997·The American Journal of Physiology·C G SchnackenbergJ P Granger
Aug 1, 1997·Journal of Hypertension·C D GoonasekeraM J Dillon
Jan 1, 1997·Kidney & Blood Pressure Research·A Just
Apr 29, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·D TanC Caramelo
Apr 30, 1998·The Biochemical Journal·A C GorrenB Mayer
Dec 9, 1998·The American Journal of Physiology·A Kurtz, C Wagner
Mar 7, 2000·Journal of the American Society of Nephrology : JASN·Anette MelkPhilip F Halloran
Sep 7, 2000·Biochemical and Biophysical Research Communications·M Mori, T Gotoh
Sep 13, 2001·Clinical and Experimental Pharmacology & Physiology·Y XiongB M Chen
Jan 5, 2002·Journal of the American College of Cardiology·Andrew J MaxwellPeter H Stone
Jan 24, 2002·Journal of the American Society of Nephrology : JASN·Carmine ZoccaliRainer Böger
Feb 19, 2002·Journal of the American College of Cardiology·Michel L HijmeringTon J Rabelink
Mar 8, 2002·Hypertension·Pablo A Ortiz, Jeffrey L Garvin
Mar 21, 2002·JAMA : the Journal of the American Medical Association·Markus C StühlingerPhilip S Tsao
Apr 6, 2002·American Journal of Physiology. Renal Physiology·Pablo A Ortiz, Jeffrey L Garvin
Jun 22, 2002·Metabolism: Clinical and Experimental·T AsagamiP S Tsao
Jun 26, 2002·Kidney International·Carmine ZoccaliUNKNOWN CREED Investigators
Sep 13, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira ItoAkira Takeshita
Sep 18, 2002·Kidney International·Katy J Bennett-RichardsLesley Rees
Oct 5, 2002·Hypertension·Eisei NoiriToshiro Fujita
Oct 12, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Pontus B Persson

❮ Previous
Next ❯

Citations

Dec 6, 2012·International Urology and Nephrology·Aysegul Kudu CobanogluErcan Ok
Apr 16, 2013·Age·Francesco PizzarelliCarmine Zoccali
May 19, 2007·Antioxidants & Redox Signaling·Donald G Buerk
Feb 13, 2007·Current Opinion in Nephrology and Hypertension·Ethan Marin, William C Sessa
Nov 10, 2007·Seminars in Dialysis·Carmine ZoccaliGiovanni Tripepi
Aug 25, 2012·Cardiology Research and Practice·Jeanie Park
Aug 22, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kumiko FurukiTsutomu Imaizumi
Dec 27, 2011·Critical Reviews in Biomedical Engineering·Donald G BuerkDov Jaron
Jun 28, 2011·Primary Care Diabetes·Dana E KingCharles J Everett
Jul 6, 2007·Peptides·Kwok Leung OngBernard M Y Cheung
Jun 3, 2015·Clinical Kidney Journal·Damian G McGroganNicholas G Inston
Nov 5, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Kenji ObayashiNorio Kurumatani
Dec 2, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A TestaC Zoccali
Mar 2, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Costas TsioufisChristodoulos Stefanadis
Dec 6, 2008·American Journal of Hypertension·Yoshitomo NotsuJunichi Masuda
Feb 12, 2011·American Journal of Hypertension·Yuichiro YanoKazuomi Kario
Jun 13, 2017·Current Medical Research and Opinion·Noeleen Berkhout-ByrneMarjolijn van Buren
Aug 3, 2017·International Journal of Molecular Sciences·Jasdeep KaurPaul J Fadel
Jan 6, 2007·Stroke; a Journal of Cerebral Circulation·Usman KhanHugh S Markus
Jun 11, 2010·Journal of Separation Science·Claudia DesiderioMassimo Castagnola
Aug 26, 2014·Journal of the American Society of Nephrology : JASN·Giovanni TripepiCarmine Zoccali
Dec 19, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Carmine Zoccali, Francesca Mallamaci
Apr 13, 2007·Journal of the American Society of Nephrology : JASN·Jan T Kielstein, Carmine Zoccali
Apr 2, 2011·Nature Reviews. Drug Discovery·James Leiper, Manasi Nandi
Nov 3, 2011·Nature Reviews. Nephrology·Alberto OrtizCarmine Zoccali
Jul 31, 2019·International Journal of Molecular Sciences·Elena Oliva-DamasoJose Carlos Rodriguez-Perez
Aug 21, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Maricica PacurariFadi G Hage
Aug 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Matthew A RobertsFrancesco L Ierino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.